For citations:

Simanenkova A.V., Minasian S.M., Karonova T.L., Vlasov T.D., Timkina N.V., Khalzova А.K., Fuks O.S., Shimshilashvili A.A., Timofeeva V.A., Borshchev Yu.Yu., Galagudza M.M. Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus. Diabetes mellitus. 2021;24(2):111-121. (In Russ.) https://doi.org/10.14341/DM12714